Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conbercept in DME and sNPDR
NCT06305143Phase 4Active, not recruiting
- Start
- Apr 2024
- Primary completion
- Jun 2025
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of conbercept in diabetic macular edema (DME). Started Apr 2024; status: active, not recruiting.
02
Drugs
conbercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT06305143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06305143.